Gene Symbol | HLA-G |
Entrez ID | 3135 |
Uniprot ID | P17693 |
Description | major histocompatibility complex, class I, G |
Chromosomal Location | chr6: 29,826,967-29,831,125 |
Ontology | GO ID | GO Term | Definition | Evidence |
---|---|---|---|---|
BP |
GO:0002474 |
antigen processing and presentation of peptide antigen via MHC class I |
The process in which an antigen-presenting cell expresses a peptide antigen on its cell surface in association with an MHC class I protein complex. Class I here refers to classical class I molecules. |
TAS |
BP |
GO:0002479 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent |
The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a TAP (transporter associated with antigen processing) pathway. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell and is dependent on TAP transport from the cytosol to ER for association with the MHC class I molecule. Class I here refers to classical class I molecules. |
TAS |
BP |
GO:0002480 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent |
The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class I protein complex following intracellular transport via a pathway not requiring TAP (transporter associated with antigen processing). The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell. Class I here refers to classical class I molecules. |
TAS |
BP |
GO:0002645 |
positive regulation of tolerance induction |
Any process that activates or increases the frequency, rate, or extent of tolerance induction. |
IMP |
BP |
GO:0002666 |
positive regulation of T cell tolerance induction |
Any process that activates or increases the frequency, rate, or extent of T cell tolerance induction. |
IMP |
BP |
GO:0002767 |
immune response-inhibiting cell surface receptor signaling pathway |
A series of molecular signals initiated by the binding of an extracellular ligand to a receptor on the surface of the target cell capable of inhibiting an immune response. |
IDA |
BP |
GO:0006968 |
cellular defense response |
A defense response that is mediated by cells. |
TAS |
BP |
GO:0019882 |
antigen processing and presentation |
The process in which an antigen-presenting cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex. |
IBA |
BP |
GO:0032735 |
positive regulation of interleukin-12 production |
Any process that activates or increases the frequency, rate, or extent of interleukin-12 production. |
IDA |
BP |
GO:0042130 |
negative regulation of T cell proliferation |
Any process that stops, prevents or reduces the rate or extent of T cell proliferation. |
IDA |
BP |
GO:0045591 |
positive regulation of regulatory T cell differentiation |
Any process that activates or increases the frequency, rate or extent of differentiation of regulatory T cells. |
IMP |
BP |
GO:0050776 |
regulation of immune response |
Any process that modulates the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus. |
TAS |
BP |
GO:0050777 |
negative regulation of immune response |
Any process that stops, prevents, or reduces the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus. |
IC |
BP |
GO:0060333 |
interferon-gamma-mediated signaling pathway |
A series of molecular signals initiated by the binding of interferon-gamma to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. Interferon gamma is the only member of the type II interferon found so far. |
TAS |
BP |
GO:0060337 |
type I interferon signaling pathway |
A series of molecular signals initiated by the binding of a type I interferon to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families. |
TAS |
BP |
GO:2001199 |
negative regulation of dendritic cell differentiation |
Any process that stops, prevents or reduces the frequency, rate or extent of dendritic cell differentiation. |
IDA |
CC |
GO:0000139 |
Golgi membrane |
The lipid bilayer surrounding any of the compartments of the Golgi apparatus. |
TAS |
CC |
GO:0005886 |
plasma membrane |
The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
IBA|TAS |
CC |
GO:0012507 |
ER to Golgi transport vesicle membrane |
The lipid bilayer surrounding a vesicle transporting substances from the endoplasmic reticulum to the Golgi. |
TAS |
CC |
GO:0016020 |
membrane |
A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. |
IDA |
CC |
GO:0030670 |
phagocytic vesicle membrane |
The lipid bilayer surrounding a phagocytic vesicle. |
TAS |
CC |
GO:0031901 |
early endosome membrane |
The lipid bilayer surrounding an early endosome. |
TAS |
CC |
GO:0042612 |
MHC class I protein complex |
A transmembrane protein complex composed of a MHC class I alpha chain and an invariant beta2-microglobin chain, and with or without a bound peptide antigen. Class I here refers to classical class I molecules. |
IEA |
CC |
GO:0071556 |
integral component of lumenal side of endoplasmic reticulum membrane |
The component of the endoplasmic reticulum membrane consisting of the gene products that penetrate only the lumenal side of the membrane. |
TAS |
MF |
GO:0003823 |
antigen binding |
Interacting selectively and non-covalently with an antigen, any substance which is capable of inducing a specific immune response and of reacting with the products of that response, the specific antibody or specifically sensitized T-lymphocytes, or both. Binding may counteract the biological activity of the antigen. |
IBA |
MF |
GO:0005102 |
receptor binding |
Interacting selectively and non-covalently with one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function. |
IPI |
MF |
GO:0042803 |
protein homodimerization activity |
Interacting selectively and non-covalently with an identical protein to form a homodimer. |
IDA|NAS |
Domain ID | Description |
---|---|
IPR001039 |
MHC class I alpha chain, alpha1 alpha2 domains |
IPR003006 |
Immunoglobulin/major histocompatibility complex, conserved site |
IPR003597 |
Immunoglobulin C1-set |
IPR007110 |
Immunoglobulin-like domain |
IPR011161 |
MHC class I-like antigen recognition-like |
IPR011162 |
MHC classes I/II-like antigen recognition protein |
IPR013783 |
Immunoglobulin-like fold |
Pathway ID | Pathway Term | Pathway Source |
---|---|---|
hsa04144 |
Endocytosis |
KEGG |
hsa04145 |
Phagosome |
KEGG |
hsa04514 |
Cell adhesion molecules (CAMs) |
KEGG |
hsa04612 |
Antigen processing and presentation |
KEGG |
hsa04650 |
Natural killer cell mediated cytotoxicity |
KEGG |
hsa04940 |
Type I diabetes mellitus |
KEGG |
hsa05166 |
HTLV-I infection |
KEGG |
hsa05168 |
Herpes simplex infection |
KEGG |
hsa05169 |
Epstein-Barr virus infection |
KEGG |
hsa05203 |
Viral carcinogenesis |
KEGG |
hsa05320 |
Autoimmune thyroid disease |
KEGG |
hsa05330 |
Allograft rejection |
KEGG |
hsa05332 |
Graft-versus-host disease |
KEGG |
hsa05416 |
Viral myocarditis |
KEGG |
WP2328 |
Allograft Rejection |
WikiPathways |
WP183 |
Proteasome Degradation |
WikiPathways |
UMLS CUI | UMLS Term |
---|---|
C0004096 |
Asthma |
Pubmed ID | Author | Year | Title |
---|---|---|---|
22617121 |
Ouandaogo et al. |
2012 |
Differences in transcriptomic profiles of human cumulus cells isolated from oocytes at GV, MI and MII stages after in vivo andin vitro oocyte maturation |
22951915 |
Haozi et al. |
2012 |
Altered gene expression profile in cumulus cells of mature MII oocytes from patients with polycystic ovary syndrome |
Gene Symbol | Entrez ID | Uniprot ID | Score |
---|---|---|---|
B2M |
567 |
P61769 |
0.62 |
HLA-G |
3135 |
P17693 |
0.89 |
FAF2 |
23197 |
Q96CS3 |
0.49 |
KLRD1 |
3824 |
Q13241 |
0.62 |
HLA-A |
3105 |
P30457 |
0.63 |
HLA-C |
3107 |
P30499 |
0.63 |
KIR2DL4 |
3805 |
Q99706 |
0.76 |
TAP1 |
6890 |
Q03518 |
0.83 |
TAP2 |
6891 |
Q03519 |
0.83 |
COPB1 |
1315 |
P53618 |
0.84 |
LILRB2 |
10288 |
Q8N423 |
0.86 |
CD8A |
925 |
P01732 |
0.87 |
LILRB1 |
10859 |
Q8NHL6 |
0.89 |